SC 13G/A

AMENDMENT NO. 5 TO SCHEDULE 13G

Company: Corbus Pharmaceuticals Holdings, Inc.
Filed: March 19, 2020
Accession Number: 0001213900-20-006823

View Document ↗ View on SEC.gov ↗